"
Posterior Uveitis - Pipeline Review, H1 2016 "is
the latest addition to MRR.Biz industry research reports collection.
Global
Markets Directs, Posterior
Uveitis - Pipeline Review, H1 2016,
provides an overview of the Posterior Uveitis pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Posterior Uveitis, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Posterior Uveitis and features dormant
and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at :
http://www.marketresearchreports.biz/sample/sample/726783
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Posterior Uveitis
-
The report reviews pipeline therapeutics for Posterior Uveitis by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Posterior Uveitis
therapeutics and enlists all their major and minor projects
-
The report assesses Posterior Uveitis therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Posterior Uveitis
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Posterior Uveitis
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Posterior Uveitis pipeline depth and focus of Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline.
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Posterior Uveitis Overview 6
Therapeutics Development 7
Pipeline Products for Posterior
Uveitis - Overview 7
Posterior Uveitis -
Therapeutics under Development by Companies 8
Posterior Uveitis - Pipeline
Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Posterior Uveitis - Products
under Development by Companies 12
Posterior Uveitis - Companies
Involved in Therapeutics Development 13
Aciont Inc. 13
Neuroptis Biotech 14
Oculis ehf 15
pSivida Corp. 16
Regeneron Pharmaceuticals, Inc.
17
Santen Pharmaceutical Co., Ltd.
18
ThromboGenics NV 19
Virogenomics BioDevelopment,
Inc. 20
Posterior Uveitis -
Therapeutics Assessment 21
Assessment by Monotherapy
Products 21
Assessment by Target 22
Assessment by Mechanism of
Action 24
Assessment by Route of
Administration 26
Assessment by Molecule Type 28
Drug Profiles 30
dexamethasone acetate - Drug
Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
dexamethasone sodium phosphate
- Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
fluocinolone acetonide SR -
Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
NOP-3 - Drug Profile 36
Product Description 36
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment